Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 1421-1425, March 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keller, R.
Right arrow Articles by Keist, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keller, R.
Right arrow Articles by Keist, R.

L-Arginine-dependent Reactive Nitrogen Intermediates as Mediators of Tumor Cell Killing by Activated Macrophages1

Robert Keller2, Michael Geiges and Ruth Keist

Immunobiology Research Group, Institute of Immunology and Virology, University of Zurich, Birchstrasse 95, CH-8050 Zurich, Switzerland

The capacities of lymphokines and of various microbes to induce in a pure population of bone marrow-derived mononuclear phagocytes tumoricidal activity and/or the production of L-arginine-dependent reactive nitrogen intermediates, measured by the release of nitrite, were comparatively assessed. These parameters were found to be closely correlated in a variety of experimental situations, i.e., enhanced by a surplus of L-arginine and abrogated by N-monomethyl-L-arginine, a selective inhibitor of L-arginine-dependent effector mechanisms. In other macrophage/tumor cell combinations, such correlation was less obvious or not at all detectable, suggesting that, in these models, L-arginine-dependent reactive nitrogen intermediates are not or not alone responsible for the mediation of tumoricidal activity by activated macrophages. Collectively, the present findings suggest that the mechanism of tumor cell killing by activated macrophages may differ, depending on the tumor cell type and the pathway of macrophage activation. Among the various effector mechanisms considered to be involved in tumor cell killing by activated macrophages, L-arginine-dependent reactive nitrogen intermediates appear to hold a major role.

1 This study was supported by the Swiss National Science Foundation (Grant 3.336.86) and the Kanton Zurich. Part of this work was done in fulfillment of the requirements for the M.D. degree for M. G. at the Faculty of Medicine, University of Zurich, Zurich, Switzerland.

2 To whom requests for reprints should be addressed.

Received 5/25/89. Revised 11/13/89. Accepted 11/27/89.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. Nishikawa, B. Chang, and M. Inoue
Inducible NO synthase inhibits the growth of free tumor cells, but enhances the growth of solid tumors
Carcinogenesis, November 1, 2004; 25(11): 2101 - 2105.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Ranjan, P. Shrivastava, S. M. Singh, A. Sodhi, and N. H. Heintz
Baculovirus P35 inhibits NO-induced apoptosis in activated macrophages by inhibiting cytochrome c release
J. Cell Sci., June 15, 2004; 117(14): 3031 - 3039.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D.-E. Hu, S. O. M. Dyke, A. M. Moore, L. L. Thomsen, and K. M. Brindle
Tumor Cell-Derived Nitric Oxide Is Involved in the Immune-Rejection of an Immunogenic Murine Lymphoma
Cancer Res., January 1, 2004; 64(1): 152 - 161.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Sodhi and S. K. Biswas
fMLP-induced in vitro nitric oxide production and its regulation in murine peritoneal macrophages
J. Leukoc. Biol., February 1, 2002; 71(2): 262 - 270.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Klimp, H. Hollema, C. Kempinga, A. G. J. van der Zee, E. G. E. de Vries, and T. Daemen
Expression of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in Human Ovarian Tumors and Tumor-associated Macrophages
Cancer Res., October 1, 2001; 61(19): 7305 - 7309.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
H. A. Naama, V. E. Mack, G. P. Smyth, P. P. Stapleton, and J. M. Daly
Macrophage Effector Mechanisms in Melanoma in an Experimental Study
Arch Surg, July 1, 2001; 136(7): 804 - 809.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Goto, K. Haruma, Y. Kitadai, M. Ito, M. Yoshihara, K. Sumii, N. Hayakawa, and G. Kajiyama
Enhanced Expression of Inducible Nitric Oxide Synthase and Nitrotyrosine in Gastric Mucosa of Gastric Cancer Patients
Clin. Cancer Res., June 1, 1999; 5(6): 1411 - 1415.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.